🇺🇸 FDA
Pipeline program

LUCAR-G39P cells product

LB2304-0001

Phase 1 mab terminated

Quick answer

LUCAR-G39P cells product for Relapsed and Refractory B-cell Non-Hodgkin Lymphoma is a Phase 1 program (mab) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Phase
Phase 1
Modality
mab
Status
terminated

Clinical trials